Werewolf Therapeutics, Inc. Common Stock
HOWL
HOWL: Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer.
moreShow HOWL Financials
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of HOWL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by HOWL's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
-
Patent Title: Separation moieties and methods of use thereof Aug. 29, 2023
-
Patent Title: Activatable interleukin-2 polypeptides and methods of use thereof Dec. 27, 2022
-
Patent Title: Activatable interleukin 12 polypeptides and methods of use thereof Sep. 27, 2022
-
Patent Title: Activatable interleukin-2 polypeptides and methods of use thereof Jun. 07, 2022
-
Patent Title: Activatable interleukin-2 polypeptides Jun. 30, 2020
-
Patent Title: Activatable interleukin 12 polypeptides Jun. 30, 2020
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on HOWL's company Twitter account
WallStreetBets
Number of mentions of HOWL in WallStreetBets Daily Discussion
HOWL News
Recent insights relating to HOWL
CNBC Recommendations
Recent picks made for HOWL stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in HOWL
Corporate Flights
Flights by private jets registered to HOWL